Variant position: 232 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 473 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SIVEHRLVSRNVVFATGAYP RLSLSFRLKRNIGYFILQTYM
Mouse SIVEHRLVSRNVVFATGAYP RLSLSFRLKRNIGYFILQTYM
Rat SIVEHRLVSRNVVFATGAYP RLSLSFRLKRNIGYFILQTYM
Chicken SIVEYRLVSKNVVFATGAYP RLSLSFRLKRNIGYFILQTYM
Drosophila TIIGYETNDRKERLATGVYQ RLSLSFKLQRNIGYFVFQTYL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
26 – 473 Gamma-aminobutyric acid receptor subunit beta-3
26 – 245 Extracellular
225 – 225 Benzamidine; agonist
228 – 241
A mutation in GABRB3 associated with Dravet syndrome.
Le S.V.; Le P.H.T.; Le T.K.V.; Kieu Huynh T.T.; Hang Do T.T.;
Am. J. Med. Genet. A 173:2126-2131(2017)
Cited for: VARIANT GLN-232;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.